digital pharma education
SURVEYS, STUDIES, AND INTERVIEWS WITH INDUSTRY THOUGHT LEADERS
In order to address Linking Omnichannel to Overall Strategy, we spoke with omnichannel stakeholders to better understand whether the underlying omnichannel efforts by individual brands are supported by their organization at both the brand level and as part of the overall organizational strategy.
This is a collaborative POV presented to the industry from The DHC Group and Relevate Health, designed to empower industry leaders and decision makers in order to measurably improve HCP engagement. In addition to thought leaders from DHC Group and Relevate Health, the findings and recommendations in this piece draw on interviews with subject matter experts.
This DHC Group POV explores how individual stakeholders within pharma companies can impact the patient experience. Included are insights derived from the 2022 DHC Summit, hosted by Genentech and the DHC Group, as well as additional consumer-level data points provided by Healthline Media that provide important context of audience behavior and attitudes. Additionally, the POV concludes with an editorial by our industry’s leading expert on customer experience, Medallia’s Richard Schwartz.
The DHC Group and partner Healio Strategic Solutions have jointly conducted two surveys of HCPs and pharma company brand marketers to assess whether the tactics and spend pharma companies invest in are effectively meeting the needs of HCPs who engage with omnichannel models.
Sign up to receive educational announcements from the DHC